Here you find Investor News of year 2001.
Ad-hoc messages issued in year 2001 can be found here.
Publications of the previous years are offered in the Archive Overview.
To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.
Receive our IR news via E-Mail, RSS Feed or SMS.
December 07, 2001 | Vardenafil: Up to 85 Percent of Men Achieved Significantly Improved Erectionsvardenafil011207_e.pdf |
December 06, 2001 | Bayer to establish management holding company with operating subsidiariesar011206_e.pdf |
December 04, 2001 | Bayer Receives FDA Approval for the Intravenous Form of Its Antibiotic Avelox® (moxifloxacin HCl)avelox_iv_e.pdf |
November 15, 2001 | Worldwide co-promotion agreement for vardenafil to treat erectile dysfunctionVardenafil_Glaxo_e.pdf |
November 14, 2001 | Earnings hampered by weak global economy and problems with Pharmaceuticals9M01_IRNews_en.pdf |
November 06, 2001 | Number of Bayer stockholders has risen by 100,000Aktionärsstruktur_e.pdf |
October 02, 2001 | Bayer acquires Aventis Crop ScienceACS_EN_10-01.pdf |
September 25, 2001 | Bayer files applications for Vardenafil in United States and Mexicovardenafil_09_01-e.pdf |
September 13, 2001 | Bayer plans to form separate companies for Health Care and Crop ProtectionAR010913_e.pdf |
September 13, 2001 | Werner Wenning will be new Bayer CEOAR010913_2_e.pdf |
August 23, 2001 | Bayer withdraws cholesterol-lowering drug in Japan toolipobay4_e.pdf |
August 17, 2001 | Facts prove that Bayer gave authorities proper notificationlipobay3_e.pdf |
August 17, 2001 | Bayer says claims are without foundationlipolit_e.pdf |
August 16, 2001 | Bayer postpones listing on Wall Streetnyse2_e.pdf |
August 09, 2001 | Sales increase, but earnings down1h2001_e.pdf |
August 08, 2001 | Bayer withdraws cholesterol-lowering drug Baycol/Lipobaylipobay2i_e.pdf |
July 16, 2001 | Bayer included in ethics indicesethik_index_e.pdf |
July 10, 2001 | Bayer aims to acquire Aventis CropScienceacs-kauf_en.pdf |
June 27, 2001 | Earnings forecast revised in the face of economic downturnoutlook2001_e.pdf |
June 12, 2001 | Bayer's pharmaceutical research strategy pays off: more than 40 substances in the pipelinepdeiv_e.pdf |
May 22, 2001 | Epidauros signs contract with Bayerepidauros_e.pdf |
April 27, 2001 | Sales up 10 percent in the first quarter of 2001LeitmeldungHV_en.pdf |
April 24, 2001 | Bayer is looking for partners for its manmade fibers businessfasern_e.pdf |
April 09, 2001 | XVIth Congress of the European Association of Urology (EAU): New compound proves to be effective regardless of severity of erectile function difficulties, cause or agevardenafil_eau.pdf |
April 09, 2001 | Bayer subsidiary Wolff Walsrode to divest Covexx Films business to Wipak of Finlandww_covexx_e.pdf |
March 15, 2001 | Significant improvement in Health Care earningsleiter_fy2000_e_internet.pdf |
March 15, 2001 | Bayer divests its remaining 30% stake in Agfa-Gevaert N.V.agfa2001e.pdf |
March 06, 2001 | Bayer increases dividend to EUR 1.40dividende01_e.pdf |
February 01, 2001 | Bayer acquires a leading maize herbicide in Europemikado_e.pdf |
January 16, 2001 | Bayer and CuraGen Enter into two Landmark AgreementsCuragen_e.pdf |
January 10, 2001 | Bayer and Millennium announce genome-derived oncology drug candidate selected for first human studiesICAST_e.pdf |
January 10, 2001 | Bayer sells its interest in titanium dioxide joint ventureTitandioxid_e.pdf |
